Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04727788 · ClinicalTrials.gov registry record

Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

A clinical trial of Kidney Transplant Rejection, sponsored by Verici Dx.

Active
Registry status
550
Enrollment target
13
Study locations

NCT04727788 is a study of Kidney Transplant Rejection that is active but no longer recruiting, run by Verici Dx. The registered enrollment target is 550 participants, below the 737-participant average among 8 other Kidney Transplant Rejection trials with a reported enrollment target (25% lower). The trial reports 13 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04727788, a study of Kidney Transplant Rejection, is active but no longer recruiting, sponsored by Verici Dx.

ACTIVE NOT RECRUITING
Registry status
550 participants
Enrollment target
13
Study locations

Study Summary

Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstitial fibrosis / tubular atrophy by correlating peripheral blood gene expression profiles with graft injury (e.g. cellular / antibody-mediated), rejection and death censored graft loss.

Conditions Studied

Kidney Transplant Rejection

Study Locations (13)

Other

  • CHU Grenoble Alpes Health Center - Grenoble
  • Bologna University - Bologna
  • Brescia University - Brescia
  • University Hospital Vall d'Hebron, Barcelona - Barcelona

Illinois

  • University of Illinois at Chicago - Chicago
  • Northwestern University - Evanston

Maryland

  • University of Maryland - Baltimore

Michigan

  • Henry Ford - Detroit

Nebraska

  • University of Nebraska Medical Center - Omaha

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2021-03-21
Est. Completion 2025-12-31

Sponsor

Verici Dx

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04727788

The ClinicalTrials.gov registry entry for NCT04727788 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 737-participant average among 8 other Kidney Transplant Rejection trials with a reported enrollment target (25% lower). The listed sponsor is Verici Dx, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Transplant Rejection appearing as the primary indexed condition, and to 0 interventions.

NCT04727788 reports 13 study locations spanning 9 distinct geographic areas - top geographies include Other, Illinois, Maryland.

Frequently Asked Questions

What is clinical trial NCT04727788 about?

NCT04727788 is a clinical study titled "Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection". Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstitial fibrosis / tubular atrophy by correlating peripheral blood gene expression profiles with graft in...

What is the current status of trial NCT04727788?

This trial is currently active not recruiting. The enrollment target is 550 participants. The study started on 2021-03-21. Estimated completion is 2025-12-31.

What conditions does trial NCT04727788 study?

This clinical trial studies the following conditions: Kidney Transplant Rejection.

Who is sponsoring clinical trial NCT04727788?

This trial is sponsored by Verici Dx, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04727788 being conducted?

This trial has 13 study locations across Illinois, Maryland, Michigan, Nebraska, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Transplant Rejection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Transplant Rejection

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.